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A B S T R A C T
Recent evidence suggests that the steroid hormone testosterone can decrease the functional coupling between
orbitofrontal cortex (OFC) and amygdala. Theoretically this decoupling has been linked to a testosterone-driven
increase of goal-directed behaviour in case of threat, but this has never been studied directly. Therefore, we
placed twenty-two women in dynamically changing situations of escapable and inescapable threat after a within-
subject placebo controlled testosterone administration. Using functional magnetic resonance imaging (fMRI) we
provide evidence that testosterone activates the left lateral OFC (LOFC) in preparation of active goal-directed
escape and decouples this OFC area from a subcortical threat system including the central-medial amygdala,
hypothalamus and periaqueductal gray. This LOFC decoupling was specific to threatening situations, a point that
was further emphasized by an absence of such decoupling in a second experiment focused on resting-state
connectivity. These results not only confirm that testosterone administration decouples the LOFC from the
subcortical threat system, but also show that this is specifically the case in response to acute threat, and ulti-
mately leads to an increase in LOFC activity when the participant prepares a goal-directed action to escape.
Together these results for the first time provide a detailed understanding of functional brain alterations induced
by testosterone under threat conditions, and corroborate and extend the view that testosterone prepares the
brain for goal-directed action in case of threat.
1. Introduction
The steroid hormone testosterone has a well-established role in the
reduction of fear and the promotion of dominance motivation and ag-
gression in many species (Mazur and Booth, 1998; Wingfield et al.,
1990). In humans, the neural mechanisms underlying these effects are
not yet clear, but it has been suggested that testosterone administration
can decouple the orbitofrontal cortex (OFC) from subcortical threat
reactivity, leading to an increase in impulse-driven and goal-directed
behaviour in response to threat (Terburg and van Honk, 2013b; van
Honk et al., 2011). Direct evidence for this hypothesis is however
currently lacking as acute threat reactivity in the brain and associated
goal-directed behaviour have not yet been studied in relation to tes-
tosterone administration.
We do know that testosterone can reduce physiological fear re-
sponses in humans (Hermans et al., 2007, 2006), and testosterone has
repeatedly been linked to subcortical-cortical decoupling (Schutter and
van Honk, 2004) and decoupling of the OFC from the amygdala in
particular (Bos et al., 2012a; van Wingen et al., 2010; Volman et al.,
2011, 2016). Although the specific functions ascribed to the OFC are
highly diverse (Stalnaker et al., 2015), it is generally accepted that its
coupling with the amygdala serves to adjust behaviour based on the
integration of top-down goal-directed action tendencies and bottom-up
emotional reactivity (Kringelbach and Rolls, 2004; Milad and Rauch,
2007; Murray and Izquierdo, 2007; Zald et al., 2014). We aimed to tap
into this function by means of a functional magnetic resonance imaging
(fMRI) experiment with dynamically changing situations of acute threat
with goal-directed escape possibilities (Montoya et al., 2015). We ap-
plied this experiment in a double-blind placebo-controlled testosterone
administration design along with a measurement of baseline resting-
state fMRI (RS-fMRI) connectivity. Using this design, we were able to
investigate the hypothesis that testosterone’s decoupling of the OFC
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Thirty healthy young women were recruited to participate in the
experiment. Ethical approval was granted by the Human Research
Ethics Committee of the University of Cape Town (UCT). Before being
invited to participate, all women were screened with self-report ques-
tionnaires for present or previous psychiatric conditions. Additional
exclusion criteria, also assessed by self-report questionnaire, were:
Current or recent use of psychotropic medications, use of hormonal
contraceptives, pregnancy, abnormal menstrual cycle, any endocrine
disorders, any other serious medical condition, left-handedness, habi-
tual smoking, hearing problems, and colour blindness. Upon their ar-
rival at the laboratory, all participants provided written informed
consent before testing began. After recruitment, four participants were
unable to complete their scans: One did not fit in the head coil, and
three could not complete scans due to electricity failure at the scan
facility. This left 26 participants who were included in the resting state
analyses. A further four were excluded from the task-based statistical
analyses: One due to excessive head movement in the scanner (40mm)
during the task, one due to coil signal failure, and two due to head-
phone failure. After these 8 exclusions, the total sample consisted of 22
participants (age range 18–37, mean age 21.3, SD=4.4), with 11 in
each administration order (placebo in first session, or testosterone in
first session). Only women were considered as participants because the
parameters (quantity and time course) for inducing neurophysiological
effects after a single sublingual administration of 0.5 mg of testosterone
are known in women, whereas these parameters are not known in men
(Tuiten et al., 2000). Each participant was paid ZAR250 for their par-
ticipation.
Fig. 1. Outline of the threat escape task. Participants are repeatedly attacked by rapidly approaching pictures. Participants can escape by pressing a button, but when
they fail to do so they will be presented with a highly aversive noise (AN). The pictures are manipulated to be distant-escapable, imminent (escapable at chance-level)
or inescapable, and all conditions are compared with an equivalent safe-context control condition involving the same procedure but without the threat of AN
exposure.
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2.2. Drug administration
We followed the procedure first reported by Tuiten et al. (2000),
which involves the sublingual administration of 0.5 mg of testosterone
with a hydroxypropyl-β-cyclodextrin carrier (manufactured by La-
boswiss AG, Davos, Switzerland) to healthy young women. Placebo
samples were similar except for the omission of testosterone. This is a
well-established single dose testosterone administration procedure that
has been widely used for nearly two decades (Tuiten et al., 2000, 2018)
and has repeatedly been shown to generate behavioural effects in young
women (see Bos et al., 2012b; van Honk et al., 2014 for reviews). For
the dosage chosen, no side effects have been reported in this or other
studies to date. See supplementary information for a more detailed
description of this administration method.
2.3. Procedure/experimental design
Participants were tested on two separate days. The first and second
session were separated by at least 48 h. Both testing days fell within the
follicular phase of the participants’ menstrual cycles to ensure low and
stable basal levels of sex hormones (e.g. progesterone, luteinizing hor-
mone, and follicle stimulating hormone). On both occasions, partici-
pants arrived at the lab to receive the drug or placebo administration in
the morning. Participants were instructed not to participate in any ac-
tivity that could cause excessive fluctuations in hormone production,
such as sports games, exams, or sexual activity. Four hours after ad-
ministration they returned to the lab to undergo MRI scanning. This
experiment was part of a larger study and all participants participated
in two other fMRI tasks, not reported in this paper.
2.4. Threat escape task (TET)
We used an active escape paradigm that has been validated in
previous pharmaco-fMRI research (Montoya et al., 2015). The task in-
vokes different stages of threat imminence using visual images that
approached (increase in size) the subject, culminating in a highly
aversive noise (AN; a 1-second ∼110 dB female scream), see Fig. 1. The
proximity of the threat, from furthest to nearest, can be distant (easily
escapable), imminent (with effort escapable at chance level), or in-
escapable. Each condition has a matched safe condition without AN
presentation, which is distinguishable by a different visual stimulus.
Each trial is presented for either 3, 4.5, or 6 s, and trials are separated
by rest phases of 3 or 4 s. In all conditions, except for the inescapable
condition, the participant can avoid AN presentation by pressing a
button in time to prevent the image from reaching full-size. The speed
of the approaching threat is controlled based on each participant’s
baseline reaction times as assessed in a practice session, and is updated
based on performance during the experiment. Upon failing to escape an
imminent attack, the duration of the following attack would be ex-
tended by 33ms, and when an imminent attack was successfully
avoided, the attack duration was shortened by 33ms. This allows for all
participants, regardless of general reaction time speed, to escape from
the imminent threat at the same probability, i.e. chance-level perfor-
mance, resulting in a reliable 50% of these trials with actual AN pre-
sentation and thus a uniform level of threat across participants. The
easily escapable trials were four times the length of the imminent trials.
Furthermore, this design allows for comparison of not only safe and
threatening conditions, but also between proximity and escapability of
threat. Finally, after the participant’s scan session they indicated their
consciously experienced level of fear in each of the six task conditions
on a Likert scale from 1 (“not afraid at all”) to 7 (“very afraid”).
2.5. Assessment of mood
In both sessions, before scanning, the participants completed the
profile of mood states 2nd edition (POMS-II) to assess baseline mood
differences due to drug administration. The POMS-II is a 65-item
questionnaire that indexes consciously experienced anger, tension/an-
xiety, depression, vigour, confusion and friendliness, as well as a
combined total mood score, using a 5-point Likert scale (Heuchert and
McNair, 2012).
2.6. 2D:4D measurement
Following evidence that prenatal testosterone exposure, as indexed
by second-to-fourth digit ratio (2D:4D), drives the effect of testosterone
on conscious but not reactive behaviour later in life (Terburg and van
Honk, 2013b), we also included this metric to our administration study.
On one of their testing days, each participant’s right hand was scanned
on a flatbed scanner, generating images that allow for accurate mea-
surement of the 2D:4D ratio. Digit lengths were measured in Adobe
Photoshop CS5 with the ruler tool from medial finger crease to middle
of fingertip (Breedlove, 2010).
2.7. fMRI acquisition
All scans were obtained using a 3 Tesla Magnetom Allegra Siemens
dedicated head MRI scanner (Siemens Medical Systems GmBH,
Erlangen, Germany) with a four-channel phased array head coil, at the
Cape Universities Brain Imaging Centre. Whole brain T2* weighted 2D-
Echo Planar Imaging (EPI) functional volumes were acquired with 36
ascending axial slices. The following parameters were used: EPI
factor=64, TR/TE: 2s/27ms, flip angle 70°, FOV (anterior-posterior,
inferior-superior, left-right): 64*64*36 slices, voxel size: 3.5 x 3.5 x
4mm. Five volumes from start of the task were discarded to allow MR
signal to stabilize, and 438 usable functional volumes were acquired. A
T1-weighted high resolution structural scan (magnetization-prepared
rapid gradient echo; MPRAGE) was obtained once for each participant
using the following parameters: TR/TE: 2.53s/6.6ms, flip angle 7°, FOV
256*256*128mm, voxel size: 1 x 1 x 1.33mm, volume acquisition time:
8 min 33s.
To investigate whether the effect of testosterone on OFC coupling is
specific to threat processing or context independent, this study also
included a resting-state fMRI session. On the same scanner and during
the same session a total of 298 functional volumes were obtained using
a standard interleaved EPI sequence using a 64*64*29 FOV, a flip angle
of 70°, a TR of 1.6 s, a TE of 27ms, and a voxel size of
3.75×3.75 x 5mm. During this 10-minute scan participants were in-
structed to remain awake and to try and clear their minds while looking
at a fixation cross.
2.8. TET analysis
2.8.1. Preprocessing
MR scans were analysed using SPM8 (Wellcome Department of
Imaging Neuroscience, London, UK). Pre-processing included; slice-
time correction, motion correction of the 6 motion parameters and the
sum of squared difference minimization, volume realignment to the
middle volume and AC-PC realignment to improve co-registration.
Functional and structural volumes were co-registered and subsequently
normalized to Montreal Neurological Institute (MNI) space using uni-
fied segmentation procedure (Ashburner and Friston, 2005) and re-
sampled into 2mm isotropic voxels using 4th degree B-spline inter-
polation. Finally, all images were smoothed using an 8mm FWHM
Gaussian kernel.
2.8.2. Functional activation analysis
The effects of testosterone on brain activity related to threat an-
ticipation were investigated within general linear models (GLM). The
task was designed to measure anticipatory BOLD responses to passively
experiencing, or actively escaping from, AN exposure. Therefore, trials
without actual attacks (12 trials for each condition) were of main
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interest, whereas trials with attacks (3 trials for each condition ex-
cluding safe/inescapable) were treated as separate variables in the
model, which ensures that the effects of motion related artefacts due to
button-presses and AN presentation do not affect our measure of in-
terest. Thereto, in the first-level GLM for each test-session, we used
twelve regressors for our trials of interest: Six for the trial-onsets (box-
car function for stimulus-duration, 3–6 s), and six for the trial-offsets
(delta function). Trial-offset regressors were included based on a pre-
vious study into threat-offset effects (Klumpers et al., 2010) but con-
sidered of no-interest for the current study. Furthermore, ten other
nuisance regressors were defined: Five for the trial-onsets for stimuli
that would attack, four for the attack-onset (box-car function for attack-
duration), and one for the AN-onset (box-car function for AN-duration,
1 s).
These regressors were all convolved with the hemodynamic re-
sponse function as implemented in the SPM8 software. In addition,
realignment parameters and a discrete cosine transform high-pass filter
with a 1/128 Hz cut-off frequency were added to the model to reduce
variance due to nuisance factors such as movement and drifts in the
signal. Thus, in total twenty-nine regressors were entered in the first
level statistical analysis. For each subject, and session, we computed
contrast maps for onset of distant-escapable, imminent-escapable and
inescapable threat and safe cues versus baseline.
For the second level analysis, these contrast maps were entered in a
full-factorial 2× 2 x 3 ANOVA design with drug (testosterone and
placebo), condition (threat and safe) and distance (distant-escapable,
imminent-escapable, inescapable) as within-subject factors. To evaluate
our hypotheses within this GLM we first tested for threat related (de)
activations in each distance condition (e.g. Inescapable
[Threat< >Safe], etc.). We next tested the two crucial comparisons,
which are (de)activations in anticipation of escapable versus inescap-
able threat (i.e. (Distant[Threat > Safe] + Imminent[Threat > Safe])
/ 2< > Inescapable[Threat > Safe]), and (de)activations in antici-
pation of high versus low threat (i.e. (Imminent[Threat > Safe] +
Inescapable[Threat > Safe]) / 2< >Distant[Threat > Safe]).
Finally, we compared (de)activations between all combinations of dis-
tances (e.g. Distant[Threat > Safe]< > Inescapable[Threat > Safe],
etc.). This three-step approach was used for general task effects as well
as for testosterone administration effects.
For identification of brain (de)activation patterns we first applied
whole-brain FWE-correction with a cluster-wise threshold of p< .05
and cluster-defining threshold p< .001. Next we aimed to identify
anatomically specific effects in the OFC and subcortical threat network
by applying FWE-correction for the region of interest (ROI) volume
with a voxel-wise threshold of p< .05. The ROIs consisted of a bilateral
midbrain mask based on the TD Lobes atlas from the WFU Pickatlas
Toolbox implemented in SPM (Maldjian et al., 2003), a bilateral
amygdala mask (Amunts et al., 2005) taken from the anatomy toolbox
as implemented in SPM8 (Eickhoff et al., 2005), a bilateral hypotha-
lamus mask created by defining an 8mm sphere around the central
coordinate (MNI coordinate: x=0, y=2, z=13) of hypothalamus sub-
regions as described by Baroncini et al (2012); (see also Terburg et al.,
2013a), and a bilateral OFC mask which includes the areas that were
sensitive to testosterone decoupling in previous studies (Bos et al.,
2012a; van Wingen et al., 2010; Volman et al., 2011, 2016), namely the
rectus and orbital parts of the superior, medial and middle frontal gyri
as defined in the AAL template (Tzourio-Mazoyer et al., 2002). See
Fig. 2 for a visualisation of these ROIs. Whole brain task effects were
linked to anatomical location using the AAL template.
2.8.3. Functional connectivity analysis
Psycho-Physiological interaction (PPI) analysis (Friston et al., 1997)
was performed to determine the functional connectivity of the OFC
with other brain regions using the PPI module implemented in SPM8. In
short, a volume of interest (VOI) was created using a 6mm sphere
around the peak-voxel coordinate of OFC activation identified in the
functional activation analysis. For each participant time-course (first-
eigenvariate) was extracted, and mean-corrected for general task ef-
fects. A new GLM was obtained using this time-course as regressor to-
gether with a regressor for the task-contrast of interest, and their in-
teraction (i.e. PPI). To maintain power, we limited this analysis to the
identification of connectivity differences in the overall condition con-
trast (threat versus safe). Finally, contrast-maps of the PPI were entered
in separate full-factorial models to test for testosterone administration
effects on threat-related OFC connectivity. Although this approach does
not allow testing for connectivity modulations based on specific threat
distances, it does provide insight into connectivity pattern modulations




Functional and anatomical images were processed using the fMRI
Signal Processing Toolbox for MATLAB (Patel et al., 2014). Anatomical
images were skull-stripped. Functional image pre-processing consisted
of core image processing and denoising. Core image processing started
with slice timing correction with the middle slide as the reference. All
frequencies except Nyquist and zero frequencies were kept. Rigid-body
parameters (3 rotations and 3 translations) and their first derivatives
necessary for head movement correction were calculated and all func-
tional images were aligned to the first frame. Next, affine transforma-
tions were calculated and used to co-register the functional data to the
skull-stripped anatomical image using a grey matter mask. Zeropadding
temporarily added 100 zeros to the end of the time series to prevent
errors in denoising the data at a later stage. The data were then
transformed to the Montreal Neurological Institute template (average of
152 brains; MNI152), T1 weighted, in standard space by non-linear
warping. Generating the CSF/WM signal involved segmentation of the
downsampled anatomical dataset to obtain CSF and WM signals from
the MNI152 template included in the signal processing toolbox.
Head movement during fMRI scans have been shown to affect
functional connectivity measures such as decreased long-distance cor-
relations and increased short-distance correlations (Van Dijk et al.,
2012). Traditional methods can remove some artefacts, but are not able
to correct for subtler artefacts, such as spike-like movements that lead
to spin-history effects. We used a data-driven method that identifies,
models, and removes motion artefacts by wavelet despiking (Patel
et al., 2014), without the need for data scrubbing. This method first
decomposes the time series into a set of scales using the Maximal
Overlap Discrete Wavelet Transform (MODWT). It then identifies
maximal and minimal wavelet coefficients and detects and removes
chains of these coefficients. Such chains are present across multiple
scales at the same point in time and represent transients of all sizes.
Lastly, the time series are recomposed from the remaining coefficients
using inverse MODWT (iMODWT). After wavelet despiking, motion,
motion derivatives, CSF and white matter were regressed out.
2.9.2. Seed-based connectivity analysis
To assess OFC connectivity modulations by testosterone, the pre-
processed wavelet despiked images were band-pass filtered
(0.1–0.01 Hz) and average time-series were extracted for the same OFC
sphere used in the PPI analyses of the TET. Whole-brain connectivity
maps were calculated based on Pearson correlations between the seed
time series and the rest of the brain. The resulting connectivity maps
were z-transformed, and these were analysed in SPM8 using a pairwise
comparison and the same statistical thresholds as used in the TET
analyses. To further explore connectivity modulations by testosterone,
we also performed this analysis using the three, bilateral, amygdala
sub-nuclei seeds obtained from an anatomical connectivity derived
amygdala sub parcellation (Bzdok et al., 2013).
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2.9.3. Whole-brain connectivity analysis
In addition to the hypothesis driven seed-based resting-state con-
nectivity analysis, we also employed a data-driven independent com-
ponent analysis (ICA) to explore potential whole brain effects of tes-
tosterone on functional connectivity. Seed-based analyses only focus on
very specific networks and connections. In contrast, independent
component analysis makes no assumptions about the underlying net-
works and thus allows a model-free analysis of any potential
differences. Analyses were carried out using Probabilistic Independent
Component Analysis (Beckmann and Smith, 2004) as implemented in
MELODIC (Multivariate Exploratory Linear Decomposition into In-
dependent Components) Version 3.14, part of FSL (FMRIB's Software
Library, www.fmrib.ox.ac.uk/fsl). The following steps were applied to
the pre-processed wavelet despiked data: masking of non-brain voxels;
voxel-wise de-meaning of the data; normalisation of the voxel-wise
variance. Pre-processed data were whitened and projected into a 35-
Fig. 2. Functional MRI findings, only significant clusters are shown. a, TET effects: All three threat conditions reliably activated the brain’s salience network
consisting of the anterior insula, dorsal ACC, thalamus and striatum. The medial prefrontal cortex deactivated particularly when under high threat conditions, the
midbrain particularly reacted to high threat, and threat evoked increased striatal activity particularly when it was escapable. b, Testosterone effects: Testosterone
activated the left lateral OFC in response to escapable threat, and decoupled this OFC cluster from the midbrain (PAG), left amygdala (CMA), hypothalamus and
medial OFC in threat compared to safe conditions.
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dimensional subspace using probabilistic Principal Component Analysis
where the number of dimensions was estimated using the Laplace ap-
proximation to the Bayesian evidence of the model order (Beckmann
and Smith, 2004), thus resulting in 35 independent components. The
whitened observations were decomposed into sets of vectors which
describe signal variation across the temporal domain (time-courses),
the session/subject domain and across the spatial domain (maps) by
optimising for non-Gaussian spatial source distributions using a fixed-
point iteration technique (Hyvarinen, 1999). Estimated Component
maps were divided by the standard deviation of the residual noise and
thresholded by fitting a mixture model to the histogram of intensity
values (Beckmann and Smith, 2004). Permutation testing was used to
assess potential effects of testosterone across all 35 components, using
5000 permutations and a threshold free cluster enhancement (TFCE) to
control for multiple comparison as implemented in FSL’s randomise
tool (Winkler et al., 2014).
2.10. Data availability
Non-thresholded statistical maps of the main fMRI analyses can be
found at the NeuroVault data repository (Gorgolewski et al., 2015):
http://neurovault.org/collections/AUIXVATH/ and http://neurovault.
org/collections/ISHJRKRU/. All other data are available on request
from the authors.
3. Results
3.1. Subjective experience data
Participants were asked to guess which session had included the
testosterone dose and they were unable to correctly guess above chance
(χ2= 0.2338, p=0.63). Additionally, POMS-II mood scales showed no
difference on the total mood scale (Heuchert and McNair, 2012) be-
tween drug conditions (t(22)= 0.928, p=0.364), and when looking at
the separate moods this was also the case for anger, vigour, confusion,
tension, and fatigue (all ps> 0.38). Depression was significantly lower
in the testosterone (1.07, SD=0.12) compared to placebo (1.15,
SD=0.20) condition (t(21)= 2.791, p=0.011), but this small differ-
ence could be considered negligible as in both conditions these scores
are near the absolute minimum of score ‘1’ which in the 5-point Likert
scale represents ‘no depression at all’.
The fear ratings regarding the AN, rated on a 7-point Likert scale,
were generally high in both drug conditions (testosterone: M=5.71,
SD=1.34; placebo: M=6.12, SD=1.01) and over both sessions
(session 1: M=6.02, SD=1.02; session 2: M=5.82 SD=1.36).
Across both drug conditions, participants reported greater fear in the
threat vs safe condition (t(21)=-21.39, p < 0.001) and also in the
inescapable vs imminent (t(21)=-3.65,p < 0.001), and imminent vs
avoidable conditions (t(21)= 4.68, p < 0.001). Paired sample T-tests
confirmed no significant difference between the two drug conditions (t
(21)=-1.7, p=0.103) or between the two sessions (t(21)=-0.78,
p=0.444).
3.2. TET results
3.2.1. General task effects
Statistics and results for the TET are summarized in Table 1, Fig. 2,
and see http://neurovault.org/collections/AUIXVATH/ for non-thre-
sholded statistical maps. In line with previous work on acute and es-
capable threat (Klumpers et al., 2010; Mobbs et al., 2007; Montoya
et al., 2015), we observed reliable threat-potentiated activity in the
salience network of the brain (anterior insula, dorsal anterior cingulate
cortex, thalamus, bed nucleus of the stria terminalis and striatum) in all
three distance conditions. Furthermore, both high threat conditions
(imminent and inescapable) evoked midbrain activity, and both es-
capable threat conditions (distant and imminent) evoked hypothalamic
reactions. Threat-related deactivations were observed in the medial
prefrontal cortex, including the medial OFC (MOFC), particularly in the
high threat conditions, and inescapable threat also deactivated areas in
the medial temporal cortex and the angular gyrus.
As can be seen in Table 1 and Fig. 2, analysis of threat level and
escapability revealed that high threat evoked midbrain reactivity, cor-
responding to the location of the periaqueductal gray (see Hermans
et al., 2013), and deactivations in medial prefrontal cortex. Striatal
reactivity to threat was strongest when the threat was escapable. Thus,
in line with previous studies (Klumpers et al., 2010; Mobbs et al., 2007;
Montoya et al., 2015) an approaching threat shifts brain activity away
from cortical towards subcortical processing, with anticipation of an
active escape response evoking striatal threat reactivity.
3.2.2. Testosterone administration effects
Testosterone had no direct effect on threat reactivity in the three
distance conditions separately1, but did increase activity in the left
lateral OFC (LOFC) in escapable compared to inescapable threatening
conditions (see Fig. 2). Post-hoc T-tests showed this was due to an in-
crease to escapable rather than a decrease to inescapable threat (see
Table 1).
PPI-analysis (see methods) using the location of this LOFC cluster
revealed that testosterone administration reduced threat-related con-
nectivity with the midbrain, hypothalamus, left amygdala and MOFC
(see Fig. 2). More specific allocation of the midbrain cluster indicated
that it corresponds to the location of the periaqueductal gray (see
Hermans et al., 2013), and the amygdala cluster corresponds to the left
central-medial amygdala (CMA; see Amunts et al., 2005). Finally, post-
hoc T-tests revealed that specifically in the testosterone condition left-
sided LOFC-CMA coupling was reduced in threat compared to safe
conditions.
3.2.3. 2D:4D analysis
To investigate the relation between testosterone administration ef-
fects and 2D:4D, beta weights were extracted from a 6mm sphere
around the LOFC peak activation identified in the testosterone/TET
analysis. These beta-weights were entered in a 2 (testosterone and
placebo) x 2 (threat and safe) x 3 (distant, imminent, and inescapable)
repeated measures ANOVA with 2D:4D as covariate. The 2D:4D cov-
ariate was non-significant (F(1,20)= 0.443, p= .513), which was also
the case for its interactions with the within-subjects variables (all
ps> .16).
3.3. RS-fMRI results
To specifically investigate testosterone’s effect during resting state,
whole-brain correlation maps (based on Fischer z-transformed Pearson
correlation maps) were computed for the LOFC seed. In both drug
conditions left LOFC connectivity was particularly strong with the right
OFC, bilateral striatum and anterior cingulate cortex (see Fig. 3).
Pairwise comparisons indicated no significant differences between
placebo and testosterone, even when applying a more liberal threshold
(p< .01 as cluster-defining threshold). Confidence interval plots for the
pairwise comparisons are available in the supplementary material. Si-
milarly, pairwise comparisons of the z-maps also indicated no sig-
nificant differences between placebo and testosterone for any of the
amygdala seeds (Bzdok et al., 2013) using the same liberal thresholds,
and exploratory ICA analysis did not reveal any differences between
drug conditions (see http://neurovault.org/collections/AUIXVATH/ for
seed-based non-thresholded statistical maps and http://neurovault.org/
collections/ISHJRKRU/ for the 35 identified ICA components).
1 This was also the case when applying a more liberal threshold; p< .01 as cluster-
defining threshold.
S.J. Heany et al. Psychoneuroendocrinology 96 (2018) 42–51
47
Table 1
Functional MRI findings from the TET. All reported clusters are activations (or deactivations, indicated with a negative T-value) to threat > safe contrasts. Clusters
are whole-brain statistics FWE cluster-wise corrected (p< .05) with cluster defining threshold p< .001, or in case of region of interest analysis (indicated with *, and
see Fig. 2 for a visualisation) FWE voxel-wise corrected (p< .05). PFC=Prefrontal Cortex, OFC=Orbitofrontal Cortex, BNST=Bed Nucleus of the Stria Terminalis,
s.c. = same cluster.




Anterior Insula Left 571 0.006 5.43 −32 20 4
Right 793 0.001 5.67 34 24 −6
Anterior Cingulate Cortex Both 1986 < .001 4.8 −6 10 38
Supplemental Motor Area Both s.c.




Midbrain* Both 321 0.002 4.39 8 −14 −10
Angular Gyrus Left 480 0.012 −4.65 −48 −60 28
Right 508 0.01 −4.61 50 −66 32
Medial OFC Both 3049 < .001 −4.89 −8 40 −8
Medial Temporal Cortex Left 617 0.004 −4.69 −48 −38 0
Medial OFC* Both 551 < .001 −4.89 −8 40 −8
Imminent





Anterior Cingulate Cortex Both 2245 < .001 6.03 2 10 48
Supplemental Motor Area Both s.c.
Hypothalamus* Both 5 0.041 2.91 −2 −2 −6
Midbrain* Both 372 < .001 4.44 6 −26 −10
Medial OFC Both 682 0.002 −4.99 4 30 -14
Dorsomedial PFC Left 441 0.017 −4.87 −20 32 44
Medial OFC* Both 227 < .001 −4.99 4 30 −14
Distant
Anterior Insula Left 897 < .001 5.55 −36 20 4
Right 706 0.002 5.97 36 24 4
Anterior Cingulate Cortex Both 1612 < .001 6.53 −6 4 48
Supplemental Motor Area Both s.c.
Striatum Both 879 0.001 5.07 8 −12 4
Thalamus Both s.c.
BNST Both s.c.
Hypothalamus* Left 31 0.013 3.28 −6 −4 −12
Threat escapability effects
Escapable > Inescapable
Medial PFC Both 1831 < .001 4.65 18 30 −4
Striatum Both s.c.
Medial Temporal Cortex Left 763 0.001 4.18 −42 −40 0
Medial OFC* Left 11 0.017 4.1 −6 56 −18
High > Low
Midbrain* Left 10 0.02 3.75 −6 −26 −10
Medial OFC Both 1607 < .001 −5.11 2 34 −16
Dorsomedial PFC Left 367 0.033 −4.39 −14 60 18
Medial Temporal Cortex Left 465 0.014 −4.01 −52 −56 −8
Medial OFC* Both 373 < .001 −5.11 2 34 −16
Left 40 0.007 −4.35 −10 52 −16
Distant > Imminent
Medial OFC* Both 90 0.003 4.56 4 30 −14
Imminent > Inescapable
Striatum Both 635 0.003 4.24 18 28 −4
Distant > Inescapable
Medial PFC Both 2260 < .001 4.75 10 24 −4
Striatum Both s.c.
Medial Temporal Cortex Left 1062 < .001 4.25 −40 −32 −6
Medial OFC* Both 367 0.004 4.48 −6 56 −18
Drug, threat escapability interactions
Testosterone > Placebo: Escapable > Inescapable
Lateral OFC Left 347 0.04 4.39 −28 48 −6
Striatum Left s.c.
Lateral OFC* Left 27 0.006 4.39 −28 48 −6
Testosterone > Placebo: Escapable
Lateral OFC* Left 2 0.044 3.82 −28 50 −4
Testosterone > Placebo: Distant > Inescapable
Lateral OFC* Left 19 0.006 4.39 −28 48 −6
(continued on next page)
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4. Discussion
This study provides evidence that a single administration of tes-
tosterone changes the activation and connectivity pattern of the left
LOFC particularly in response to acute threat. Testosterone activates the
left LOFC in situations of goal-directed escape anticipation, and de-
couples the left LOFC from a subcortical threat network (i.e. CMA,
hypothalamus, and PAG) during threatening compared to safe situa-
tions.
To start with the latter, this testosterone induced LOFC-subcortex
decoupling can theoretically either constitute a loss of top-down control
over the subcortical threat system, or a decrease of bottom-up input to
the LOFC. We cannot assess the direction of this effect directly in the
present data, but given that we find reliable threat-reactivity in this
subcortical threat system, which does not change after testosterone
administration, a loss of top-down control seems unlikely.
Alternatively, testosterone might act to prevent subcortically generated
threat reactivity from influencing the OFC. Following the view that
OFC-amygdala connectivity serves to adjust behaviour based on the
integration of top-down goal-directed action tendencies and bottom-up
affective reactivity (Kringelbach and Rolls, 2004; Milad and Rauch,
2007 Murray and Izquierdo, 2007 Zald et al., 2014), testosterone might
therefore push OFC processing towards goal-directed action. Further
support for this view can be found in our observation that testosterone
specifically boosts LOFC activity in situations that require such a goal-
directed action, i.e. active escape from a threat. Although we cannot
assess any behavioural benefit from this testosterone-driven LOFC ac-
tivity with the present design –given that it adjusts to the behaviour of
the participant to keep threat levels stable across participants– these
results do follow the hypothesis that testosterone can promote goal-
directed action in case of threat (Terburg and van Honk, 2013b; van
Honk et al., 2011).
An interesting aspect of the present findings is the functional dis-
tinction between LOFC and MOFC. Both areas are structurally (Murray
and Izquierdo, 2007) and functionally (Zald et al., 2014) connected to
the amygdala, but in the MOFC this connection has been linked to
impulse control and reward drive, whereas in the LOFC it has been
linked to adjustment of behaviour in case of potential punishment
(Kringelbach and Rolls, 2004; Milad and Rauch, 2007). This seems to be
in line with the MOFC deactivation in response to high threat observed
here and in previous studies (Mobbs et al., 2007; Montoya et al., 2015).
Moreover, the fact that testosterone boosts the LOFC particularly in
situations of goal-directed escape anticipation seamlessly links to the
LOFC’s sensitivity to potentially punishing or dangerous situations.
Interestingly, testosterone has also been linked to a down regulation
of MOFC activity in relation to social aggression (Mehta and Beer,
2010). The possibility that this reflects reduced impulse control is
consistent with evidence that testosterone levels in adolescent boys
predict reduced MOFC-amygdala connectivity and increased alcohol
use (Peters et al., 2015). Furthermore, increased socially aggressive
Table 1 (continued)
Structure Hemisphere Cluster size p-value Peak T-value MNI-coordinate
X Y Z
Drug, psycho-physiological interactions
PPI of Threat > Safe with LOFC signal: Placebo > Testosterone
Medial Temporal Cortex Right 1539 < .001 5.44 60 −44 14
Superior Temporal Cortex Right 785 < .001 5.33 54 −22 2
Anterior Insula Right s.c.
Striatum Right s.c.
Hypothalamus* Both 67 0.012 3.58 0 −4 −18
Midbrain* Right 13 0.018 4.14 10 −32 −12
Medial OFC* Both 12 0.024 4.44 2 56 −10
Amygdala* Left 45 < .001 5.33 −22 −8 −8
PPI of Threat > Safe with LOFC signal: Testosterone
Amygdala* Left 26 0.003 −4.64 −26 −8 −8
Fig. 3. Resting state connectivity of the left lateral OFC. Connectivity was particularly strong with the bilateral OFC, striatum and anterior cingulate cortex. This
pattern was similar after testosterone and placebo administration.
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impulses have been observed in a range of testosterone administration
studies (e.g. Terburg et al., 2012, 2016; van Honk et al., 2001), and
have been associated with activation in the subcortical threat system
(Goetz et al., 2014; Hermans et al., 2008).
A possible confound in a threat-escape task is that individual dif-
ferences in performance can potentially affect likelihood of receiving
the aversive stimulus. We controlled for this possibility by adjusting the
attack-speed of the task-stimuli to the individual performance such that
the imminent conditions were escapable in ∼50% of the cases for each
individual. This adjustment created a situation wherein distant threats
were always, and for each and every participant, easily escapable, im-
minent threats were always very hard to escape from (∼50%) and in-
escapable threats were always inescapable. This was done in order to
ensure that threat-type and escapability are exactly similar for all our
participants, but introduces the limitation that escape performance
cannot be directly measured. Our results should therefore be inter-
preted in relation to the preset escapability levels (i.e. distant, imminent
and inescapable) and not in terms of individual escape performance.
Taken together, these data provide a solid foundation for the view
that testosterone decouples the OFC from the amygdala under threat
(Terburg and van Honk, 2013b; van Honk et al., 2011). In this frame-
work, the here observed reduction of bottom-up amygdala-LOFC cou-
pling serves goal-directed action, while reductions in top-down control
from the MOFC underlie risk taking and social aggression. Future stu-
dies should address this interplay of testosterone with fear and ag-
gression directly, with the hypothesis that testosterone prepares the
human brain for aggressive as well as evasive action in response to
threat by decoupling the OFC from the subcortical threat system.
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